Summary:
Click image to enlarge
Acne Vulgaris affects an estimated 50 million people in the United States. Center for Clinical Studies is conducting a clinical research trial for volunteers, ages 9 and older to assess the safety and tolerability of an investigational topical foam on moderate to severe facial acne vulgaris.
Qualified Participants Must:
Be ages 9 and over
Have a minimum inflammatory lesion count of 20 to 50 inflammatory lesions on the face
Have a minimum of 25 to 100 blackheads or whiteheads on the face
Subjects must be willing to only use the non-medicated cleanser provided during the study period
Willing to complete all visits during the 18 week time period
Must meet additional inclusion and exclusion criteria
Qualified Participants May Receive:
Study-related exams and study-related medication are available at no cost. Reimbursement will be provided to qualified participants.